Clinical trial
A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of…
NCT00032396 · Control Delivery Systems, Industry · Unknown status
Key facts
| NCT number | NCT00032396 |
|---|---|
| Title | A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration |
| Lead sponsor | Control Delivery Systems, Industry |
| Collaborators | Bausch & Lomb Incorporated Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Drug |
| Interventions | Retisert Implant |
| Start date | Nov 1, 2001 |
| First posted | Mar 22, 2002 |
| Last update posted | May 29, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: